Patent Yard Sign in
Canadian application, no grantCanada

Cdna sequence of dengue virus serotype 1 (singapore strain)

CA 2134666 A1 · Owner: Yap, Eu-Hian · Inventors: Fu, Jianlin; Yap, Eu-Hian; Tan, Boon-Huan

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

2134666 9322440 PCTABS00027, DEN1-S275/90 (ECACC V92042111) is a new strain of Dengue virus serotype 1. The complete cDNA sequence of this virus has been cloned and protein-coding fragments thereof have been used in the construction of expression plasmids. DEN1-S275/90 in inactivated form, DEN1-S275/90 polypeptides or fusion proteins thereof can be incorporated into vaccines for immunisation against DEN1-S275/90 and other DEN1 viruses. The invention further provides diagnostic reagents e.g. labelled antibodies to DEN1-S275/90 proteins and, kits to detect DEN1 virus.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed April 28, 1993. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 28, 2013.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 28, 2015.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledApril 28, 1993
GrantedNo grant recorded
Term endedApril 28, 2013
Patent numberCA 2134666 A1
Classification (IPC)C12N15/40 +2 more

Timeline

Timeline From CIPO dates

1994199619982000200220042006200820102012Application filedApril 28, 1993Term endedApril 28, 2013

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.